Current Edition


Recent FDA Advancements in Rare Diseases – Funding, Partnerships, and Programs

The paucity of therapeutic choices is a reality often acknowledged by the US Food and Drug Administration (FDA) as it reviews applications for new medical …

Continue Reading →

RLS bags $10M to trial dry powder inhaled CBD in anxiety

Investors have bought into Receptor Life Sciences’ vision of treating acute anxiety disorders using a dry powder inhaled cannabidiol (CBD). With $9.7 million in fresh …

Continue Reading →

Bayer leads $80M funding round for Cellino, betting on new cell therapy manufacturing platform

Since it was established in 2017, Cellino Biotech has offered an intriguing approach to stem cell therapy manufacturing, combining biology, laser physics, gene editing tools …

Continue Reading →

Totus tots up $40M in series A funding to go after competitive cancer space

Totus Medicines is making a play for the PI3Kα inhibitor market. Exiting stealth with a $40 million series A round, the Massachusetts-based biotech plans to …

Continue Reading →

VarmX Raises € 12.5 Million to Develop Modified Blood Coagulation Factor X for Treating Severe Bleeding in Patients Using Anti-Coagulants Funding enables clinical stage trials of lead compound PseudoXa

€ 7.5 million Series A financing from lead investor BioGeneration Ventures (BGV) and Dutch regional development company InnovationQuarter Financing supplemented by € 5.0 million innovation …

Continue Reading →
clinical trials

Clinical Trial Access to Expand Following Receipt of Additional Funding

Elligo Health Research receives $16 million to expand its programs. Austin, Texas-based Elligo Health Research is a company focused on expanded access to clinical trials. …

Continue Reading →